$GWPH Recent Headlines GW Pharmaceuticals - A Ma
Post# of 72749
Posted On: 02/03/2014 3:42:26 PM
$GWPH Recent Headlines
GW Pharmaceuticals - A Marijuana Stock With Monster Potential If Sativex Wins U.S Approval 2:52 p.m. Jan. 13, 2014 - Seeking Alpha
Capitalizing On Cannabis: Key Considerations For Cannabis Stock Investors 8:05 a.m. Jan. 13, 2014 - Seeking Alpha
Medical Marijuana, GW Pharma rally amid Colorado euphoria; peers tumble 5:25 p.m. Jan. 9, 2014 - Seeking Alpha
GW Pharmaceuticals Prices 2.44M ADS Offering at $36.00/ADS 5:06 a.m. Jan. 9, 2014 - benzinga.com
High times are here for Colorado marijuana sellers, risk-tolerant investors 4:49 p.m. Jan. 3, 2014 - Seeking Alpha
High times are here for Colorado marijuana sellers, risk-tolerant investors 4:49 p.m. Jan. 3, 2014 - Seeking Alpha
The 5 Hottest IPOs of 2013 3:45 a.m. Dec. 4, 2013 - InvestorPlace.com
GW Pharma's Sativex Gets Swiss Nod - Analyst Blog 6:10 p.m. Nov. 29, 2013 - Zacks.com
UPDATE: Piper Jaffray Initiates Coverage on GW Pharmaceuticals on Expected Attractive Returns 9:47 a.m. Nov. 27, 2013 - benzinga.com
Capitalizing On Cannabis: New Leaders Emerge From A Cloud Of Pink Smoke 6:05 a.m. Nov. 25, 2013 - Seeking Alpha
GW Pharmaceuticals' CEO Discusses F4Q2013 Results - Earnings Call 1:34 p.m. Nov. 19, 2013 - Seeking Alpha
Medical Marijuana, Inc: Definitely A Dope Opera 7:00 a.m. Nov. 18, 2013 - Seeking Alpha
Cannabis Stock Analyst Talks About High Revenue Potential 3:08 p.m. Nov. 15, 2013 - benzinga.com
GW Pharma: Capitalizing On Cannabis Science 12:30 p.m. Nov. 11, 2013 - Seeking Alpha
GW Pharmaceuticals Initiates Phase 1b/2a Clinical Trial for GBM 5:24 a.m. Nov. 11, 2013 - benzinga.com
Capitalizing On Cannabis: Some Sizzle In The Sector 6:16 a.m. Oct. 27, 2013 - Seeking Alpha
Data on GW Pharma's Sativex - Analyst Blog 6:00 p.m. Oct. 3, 2013 - Zacks.com
Capitalizing On Cannabis: Divergence Among The Pot Stocks 7:00 a.m. Sept. 27, 2013 - Seeking Alpha
Sativex Pricing Agreement for GW Pharma - Analyst Blog 3:05 p.m. Sept. 24, 2013 - Zacks.com
GW Pharmaceuticals Announces Agreement on Sativex Pricing in Germany 4:46 a.m. Sept. 23, 2013 - benzinga.com
GW Pharmaceuticals to Report Q1 2014 Financial Results and Host Conference Call on 5 February, 2014 2:00 a.m. Jan. 29, 2014 - GlobeNewswire
Mentor Capital Cannabis Index Up 325% in First Three Weeks of 2014 11:26 a.m. Jan. 22, 2014 - BusinessWire - BZX
GW Pharmaceuticals plc Announces the Closing of Its U.S. Follow-on Offering of American Depositary Shares (ADSs) on the NASDAQ Global Market and Full Exercise of Underwriters' Option to Purchase Additional ADSs 11:18 a.m. Jan. 14, 2014 - GlobeNewswire
Healthcare Companies Report Petition Submission, Pricing of Follow-On Offerings and Stock Price Movements - Research Report on Johnson & Johnson, GW Pharma, Conatus Pharma, Chelsea, and Insmed 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Ipsen and GW Pharmaceuticals plc Enter Into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America 2:00 a.m. Jan. 14, 2014 - GlobeNewswire
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex® in Latin America 1:00 a.m. Jan. 14, 2014 - BusinessWire - BZX
Small Cap Buzz: GW Pharmaceuticals, Intercept Pharmaceuticals, Medbox Inc, GreenGro Technologies 11:19 a.m. Jan. 13, 2014 - ACCESSWIRE
GW Pharmaceuticals plc Announces Pricing of U.S. Follow-On Offering of ADSs Raising $87.9 Million on NASDAQ Global Market 11:05 p.m. Jan. 8, 2014 - PR Newswire
GW Pharmaceuticals Files Registration Statement for Proposed Follow-On Offering 9:07 a.m. Dec. 20, 2013 - PR Newswire
GW Pharmaceuticals plc Announces U.S. Patent Allowance for Use of Cannabinoids in Treating Glioma 2:00 a.m. Dec. 11, 2013 - PR Newswire
Edison highlights the potential of GW Pharmaceuticals' cannabinoid pipeline and furthers its US healthcare presence 10:01 a.m. Dec. 10, 2013 - PR Newswire
Events, Marketing Recommendation, FDA Meeting, and Marketing Authorization - Research Report on Hospira, Novo Nordisk, Repros Therapeutics, GW Pharmaceuticals, and Envision Healthcare 8:00 a.m. Dec. 2, 2013 - PR Newswire
GW Pharmaceuticals to Present at the Piper Jaffray 25th Annual Health Care Conference 2:00 a.m. Dec. 2, 2013 - PR Newswire
GW Pharmaceuticals plc Announces Sativex® Regulatory Approval in Switzerland 2:00 a.m. Nov. 27, 2013 - PR Newswire
GW Pharmaceuticals plc Reports 2013 Q4 and Full Year Financial Results 2:00 a.m. Nov. 19, 2013 - PR Newswire
GW Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference 1:00 p.m. Nov. 18, 2013 - PR Newswire
GW Pharmaceuticals Provides Update on Orphan Program in Childhood Epilepsy for Epidiolex® 2:00 a.m. Nov. 15, 2013 - PR Newswire
GW Pharmaceuticals to Report 2013 Q4 and Full Year Financial Results and Host Conference Call on 19 November, 2013 2:00 a.m. Nov. 12, 2013 - PR Newswire
GW Pharmaceuticals Commences Phase 1b/2a Clinical Trial for the Treatment of Glioblastoma Multiforme (GBM) 2:00 a.m. Nov. 11, 2013 - PR Newswire
GW Pharmaceuticals Announces Successful Closing of Mutual Recognition Procedure for Sativex® in France 1:00 a.m. Oct. 21, 2013 - PR Newswire
GW Pharmaceuticals - A Marijuana Stock With Monster Potential If Sativex Wins U.S Approval 2:52 p.m. Jan. 13, 2014 - Seeking Alpha
Capitalizing On Cannabis: Key Considerations For Cannabis Stock Investors 8:05 a.m. Jan. 13, 2014 - Seeking Alpha
Medical Marijuana, GW Pharma rally amid Colorado euphoria; peers tumble 5:25 p.m. Jan. 9, 2014 - Seeking Alpha
GW Pharmaceuticals Prices 2.44M ADS Offering at $36.00/ADS 5:06 a.m. Jan. 9, 2014 - benzinga.com
High times are here for Colorado marijuana sellers, risk-tolerant investors 4:49 p.m. Jan. 3, 2014 - Seeking Alpha
High times are here for Colorado marijuana sellers, risk-tolerant investors 4:49 p.m. Jan. 3, 2014 - Seeking Alpha
The 5 Hottest IPOs of 2013 3:45 a.m. Dec. 4, 2013 - InvestorPlace.com
GW Pharma's Sativex Gets Swiss Nod - Analyst Blog 6:10 p.m. Nov. 29, 2013 - Zacks.com
UPDATE: Piper Jaffray Initiates Coverage on GW Pharmaceuticals on Expected Attractive Returns 9:47 a.m. Nov. 27, 2013 - benzinga.com
Capitalizing On Cannabis: New Leaders Emerge From A Cloud Of Pink Smoke 6:05 a.m. Nov. 25, 2013 - Seeking Alpha
GW Pharmaceuticals' CEO Discusses F4Q2013 Results - Earnings Call 1:34 p.m. Nov. 19, 2013 - Seeking Alpha
Medical Marijuana, Inc: Definitely A Dope Opera 7:00 a.m. Nov. 18, 2013 - Seeking Alpha
Cannabis Stock Analyst Talks About High Revenue Potential 3:08 p.m. Nov. 15, 2013 - benzinga.com
GW Pharma: Capitalizing On Cannabis Science 12:30 p.m. Nov. 11, 2013 - Seeking Alpha
GW Pharmaceuticals Initiates Phase 1b/2a Clinical Trial for GBM 5:24 a.m. Nov. 11, 2013 - benzinga.com
Capitalizing On Cannabis: Some Sizzle In The Sector 6:16 a.m. Oct. 27, 2013 - Seeking Alpha
Data on GW Pharma's Sativex - Analyst Blog 6:00 p.m. Oct. 3, 2013 - Zacks.com
Capitalizing On Cannabis: Divergence Among The Pot Stocks 7:00 a.m. Sept. 27, 2013 - Seeking Alpha
Sativex Pricing Agreement for GW Pharma - Analyst Blog 3:05 p.m. Sept. 24, 2013 - Zacks.com
GW Pharmaceuticals Announces Agreement on Sativex Pricing in Germany 4:46 a.m. Sept. 23, 2013 - benzinga.com
GW Pharmaceuticals to Report Q1 2014 Financial Results and Host Conference Call on 5 February, 2014 2:00 a.m. Jan. 29, 2014 - GlobeNewswire
Mentor Capital Cannabis Index Up 325% in First Three Weeks of 2014 11:26 a.m. Jan. 22, 2014 - BusinessWire - BZX
GW Pharmaceuticals plc Announces the Closing of Its U.S. Follow-on Offering of American Depositary Shares (ADSs) on the NASDAQ Global Market and Full Exercise of Underwriters' Option to Purchase Additional ADSs 11:18 a.m. Jan. 14, 2014 - GlobeNewswire
Healthcare Companies Report Petition Submission, Pricing of Follow-On Offerings and Stock Price Movements - Research Report on Johnson & Johnson, GW Pharma, Conatus Pharma, Chelsea, and Insmed 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Ipsen and GW Pharmaceuticals plc Enter Into Agreement for Ipsen to Promote and Distribute Sativex(R) in Latin America 2:00 a.m. Jan. 14, 2014 - GlobeNewswire
Ipsen and GW Pharmaceuticals plc Enter into Agreement for Ipsen to Promote and Distribute Sativex® in Latin America 1:00 a.m. Jan. 14, 2014 - BusinessWire - BZX
Small Cap Buzz: GW Pharmaceuticals, Intercept Pharmaceuticals, Medbox Inc, GreenGro Technologies 11:19 a.m. Jan. 13, 2014 - ACCESSWIRE
GW Pharmaceuticals plc Announces Pricing of U.S. Follow-On Offering of ADSs Raising $87.9 Million on NASDAQ Global Market 11:05 p.m. Jan. 8, 2014 - PR Newswire
GW Pharmaceuticals Files Registration Statement for Proposed Follow-On Offering 9:07 a.m. Dec. 20, 2013 - PR Newswire
GW Pharmaceuticals plc Announces U.S. Patent Allowance for Use of Cannabinoids in Treating Glioma 2:00 a.m. Dec. 11, 2013 - PR Newswire
Edison highlights the potential of GW Pharmaceuticals' cannabinoid pipeline and furthers its US healthcare presence 10:01 a.m. Dec. 10, 2013 - PR Newswire
Events, Marketing Recommendation, FDA Meeting, and Marketing Authorization - Research Report on Hospira, Novo Nordisk, Repros Therapeutics, GW Pharmaceuticals, and Envision Healthcare 8:00 a.m. Dec. 2, 2013 - PR Newswire
GW Pharmaceuticals to Present at the Piper Jaffray 25th Annual Health Care Conference 2:00 a.m. Dec. 2, 2013 - PR Newswire
GW Pharmaceuticals plc Announces Sativex® Regulatory Approval in Switzerland 2:00 a.m. Nov. 27, 2013 - PR Newswire
GW Pharmaceuticals plc Reports 2013 Q4 and Full Year Financial Results 2:00 a.m. Nov. 19, 2013 - PR Newswire
GW Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference 1:00 p.m. Nov. 18, 2013 - PR Newswire
GW Pharmaceuticals Provides Update on Orphan Program in Childhood Epilepsy for Epidiolex® 2:00 a.m. Nov. 15, 2013 - PR Newswire
GW Pharmaceuticals to Report 2013 Q4 and Full Year Financial Results and Host Conference Call on 19 November, 2013 2:00 a.m. Nov. 12, 2013 - PR Newswire
GW Pharmaceuticals Commences Phase 1b/2a Clinical Trial for the Treatment of Glioblastoma Multiforme (GBM) 2:00 a.m. Nov. 11, 2013 - PR Newswire
GW Pharmaceuticals Announces Successful Closing of Mutual Recognition Procedure for Sativex® in France 1:00 a.m. Oct. 21, 2013 - PR Newswire
(0)
(0)